Molecules specifically binding pancreatic beta cells biomarkers

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8981053
APP PUB NO 20140105823A1
SERIAL NO

14125689

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides a synthetic peptide molecule that specifically binds an FXYD2-gamma isoform of pancreatic beta cells, said synthetic peptide molecule has 25 amino acids.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UNIVERSITE LIBRE DE BRUXELLESAVENUE F D ROOSEVELT 50 BRUXELLES 1050
UNIVERSITE DE MONS7000 MONS
EUROGENTEC SA4102 SERAING

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Beckers, Marie-Claire Angleur, BE 3 13
Burtea, Carmen Mons, BE 3 3
Eizirik, Decio L Dilbeek, BE 3 6
Flamez, Daisy Sint-Kwintens-Lennik, BE 2 6
Laurent, Sophie Boussu, BE 15 13
Muller, Robert Mons, BE 67 650
Sermeus, Corine Silly, BE 1 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 17, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00